Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations.

about

Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study.

P2860

Q48136890-94B5E9CB-7894-4BA7-B8C7-AB0861DAC7C4

P2860

Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations.

Item

http://www.wikidata.org/entity/Q42363042

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Refining the role of pegfilgra ...... nsus guidance recommendations.

@en

Refining the role of pegfilgrastim

@nl

type

Item

label

Refining the role of pegfilgra ...... nsus guidance recommendations.

@en

Refining the role of pegfilgrastim

@nl

prefLabel

Refining the role of pegfilgra ...... nsus guidance recommendations.

@en

Refining the role of pegfilgrastim

@nl

P1476

Refining the role of pegfilgra ...... nsus guidance recommendations.

@en

P2093

Carlos Camps

http://www.w3.org/2001/XMLSchema#string

Hans Tesch

http://www.w3.org/2001/XMLSchema#string

Hartmut Link

http://www.w3.org/2001/XMLSchema#string

John Glaspy

http://www.w3.org/2001/XMLSchema#string

Marco Danova

http://www.w3.org/2001/XMLSchema#string

Mario Campone

http://www.w3.org/2001/XMLSchema#string

Matti Aapro

http://www.w3.org/2001/XMLSchema#string

Ralph Boccia

http://www.w3.org/2001/XMLSchema#string

Robert Leonard

http://www.w3.org/2001/XMLSchema#string

Sylvain Choquet

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials

Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis

A randomized, double-blind, active control, multicenter, dose-finding study of lipegfilgrastim (XM22) in breast cancer patients receiving myelosuppressive therapy.

Pegfilgrastim prophylaxis is associated with a lower risk of hospitalization of cancer patients than filgrastim prophylaxis: a retrospective United States claims analysis of granulocyte colony-stimulating factors (G-CSF)

Effectiveness of daily versus non-daily granulocyte colony-stimulating factors in patients with solid tumours undergoing chemotherapy: a multivariate analysis of data from current practice.

First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study.

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.

Management of febrile neutropaenia: ESMO Clinical Practice Guidelines.

Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropenia.

Efficacy and safety of lipegfilgrastim versus pegfilgrastim: a randomized, multicenter, active-control phase 3 trial in patients with breast cancer receiving doxorubicin/docetaxel chemotherapy

P2888

s00520-017-3842-1

P304

3295-3304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S00520-017-3842-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Iwona Hus

P5008

ScienceSource

P577

2017-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091341424

http://www.w3.org/2001/XMLSchema#string

P698

28842778

http://www.w3.org/2001/XMLSchema#string

P921

Alcoal

peptide

manufactured product

chemotherapy-induced febrile neutropenia

macromolecular substances

P932

5610660

http://www.w3.org/2001/XMLSchema#string

Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations.

about

P2860

P2860

Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P5008

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P5008

P577

P6179

P698

P921

P932